Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1596, 2007-01, pp. : 23-23
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lumiracoxib has no significant effect on ethinylestradiol/levonorgestrel PK or PD parameters
Reactions Weekly, Vol. 1, Iss. 1008, 2004-01 ,pp. :
Access to resources
Recommend
Injectable fomepizole [`Antizol'; Paladin Labs] has been granted priority review status in Canada
Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. :
Ethinylestradiol/levonorgestrel effective in PMDD
Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. :
Low-Dose Ethinylestradiol/Levonorgestrel
By Dando Toni M. Curran Monique P.
Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. :
Ethinylestradiol/levonorgestrel a continuing success
Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. :